To assess whether GSK3β activity mediated the apoptotic effect of DT-061, we analyzed CLL cell viability/apoptosis after 24 h-treatment with 15 μM DT-061 combined with 5 μM SB216763 (n = 6). The gene discussed is GSK3B; the disease is B-cell chronic lymphocytic leukemia.